Since 2012, T-Lab has been at the forefront of regenerative medicine, providing Platelet Rich Plasma tubes that have facilitated over 2 million treatments globally. These Class II Medical Devices ensure the highest platelet dose and purity while being economical for clinics, guaranteeing that you never have to compromise on quality with these tubes. The package includes two sterile CE classified PRP tubes, each containing sodium citrate anticoagulant, ensuring a smooth, autologous treatment process with reduced swelling or bruising.
The two 10ml tubes yield 4ml of PRP per use, making them ideal for skin rejuvenation, hair restoration, and orthopaedic treatments—versatility is essential. T-Lab PRP shines in its straightforward design—utilizing micropolishing technology, premium materials, and a pH-neutral anticoagulant to achieve remarkable platelet recovery rates for optimal patient outcomes. By excluding homologous components like thixotropic gels, the integrity of natural growth factors and plasma quality is preserved from extraction to treatment.
T-Lab PRP undergoes regular evaluations by independent physicians, and the IMCAS 2023 Neutral DEPA Analysis Results indicate:
95.2% Purity
4.4 Billion platelet concentration
82.6% Platelet recovery rate
Why opt for T-Lab Tubes in your clinic?
1. Injectable
Unlike many options available, T-LAB PRP Tubes are not merely Blood Storage Devices or Blood Separation Kits. They are specifically crafted to produce injectable platelet-rich plasma.
2. CE Class IIB Certification
Under UK regulations, non-invasive devices that alter the biological or chemical composition of blood or other liquids intended for body infusion fall under Class IIb, necessitating this certification for any PRP tube.
3. Pre-Injected Anticoagulant
T-Lab PRP Tubes are supplied with an anticoagulant already incorporated, ensuring consistent anticoagulant quality and minimizing misuse risk, as these tubes arrive prefilled and ready for immediate application.
4. Gel-Free
Several competitors use thixotropic gels derived from polymers or hydrogels. T-Lab avoided these for two key reasons:
Studies reveal that platelets can become trapped below the gel or fail to separate correctly due to the gel's consistency, reducing effectiveness and platelet recovery rate.
This area lacks regulatory oversight, meaning no established standards exist for incorporating polymers into human treatments.
Additionally, gel formulations raise the likelihood of allergic or adverse reactions in patients.
